Pioneering gene therapy gets green light — and $475000 price – The CT Mirror
The CT Mirror |
Pioneering gene therapy gets green light — and $475000 price
The CT Mirror The country’s first approved gene therapy — approved Wednesday to fight leukemia that resists standard therapies — will cost $475,000 for a one-time treatment, its manufacturer announced. Switzerland-based Novartis, which makes the innovative therapy … Has the Era of Gene Therapy Finally Arrived? – Scientific American …Scientific American (blog) First gene therapy that targets leukemia approved in the US …kwbe Gene therapy Kymriah: What’s in a name? | BioWorldBioWorld Online CNBC –KTRK-TV –The Pharma Letter (registration) all 36 news articles » |
WJBD Online |
First gene therapy that targets leukemia approved in the US
WJBD Online Called “CAR-T cell therapy,” it is the first gene therapy to enter the U.S. market. Novartis Pharmaceuticals priced the one-time infusion at $475,000. However, the company said it would waive costs for patients who didn’t respond to the treatment … |
KTIC |
First gene therapy that targets leukemia approved in the US | KTIC …
KTIC (NEW YORK) — The Food and Drug Administration has approved a landmark treatment that genetically modifies a patient’s blood cells to target and destroy … |
kwbe |
First gene therapy that targets leukemia approved in the US
kwbe Called “CAR-T cell therapy,” it is the first gene therapy to enter the U.S. market. Novartis Pharmaceuticals priced the one-time infusion at $475,000. However, the company said it would waive costs for patients who didn’t respond to the treatment … |
Retraction Watch (blog) |
Weekend reads: Publishing too much?; CRISPR doubts; Pharma in predatory journals
Retraction Watch (blog) (Soumya Chatterjee, The News Minute); Scientists raise doubts about the validity of a high-profile Nature paper about using CRISPR gene editing in human embryos, suggesting that many of the embryos weren’t actually edited. (Paul Knopfler, The Niche … |